Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3
Published January 19, 2022 · Recall initiated: December 15, 2021
Summary
FDA records drug Class I recall D-0375-2022, published January 19, 2022 and initiated December 15, 2021. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Terminated; Reported quantity: 96 tubes; Lot: Lot# AC13786, exp. date DEC 2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
What to do
Voluntary: Firm initiated · Letter
Get an email if CLOBETASOL PROPIONATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLOBETASOL PROPIONATE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Distributor
- Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
- UPC
- 0351672129422
- Lot
- Lot# AC13786, exp. date DEC 2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,September 2, 2026
- FDAClobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.February 1, 2023
- FDANitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bottles, Rx only, Manufactured byJanuary 19, 2022
- FDASufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mLJanuary 19, 2022
- FDAClobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA,February 20, 2019
- FDAClobetasol Propionate Cream USP, 0.05% 60 g tube, Rx only Mfd. by: Taro Pharmaceutical Industries Ltd., HaifaFebruary 7, 2018
Questions about this recall
Was Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3 recalled?
Yes. FDA published recall D-0375-2022 on January 19, 2022. Reported hazard: Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLOBETASOL PROPIONATE. UPC: 0351672129422.